Who invested in Moleculent?
3 investors are on record as having backed Moleculent — Mapping cell communication to understand diseases, in Biotech, Sweden. Each row below says whether the round came from the investor's own portfolio page or from the press.
moleculent.comMoleculent investors
Rubicon Healthcare Partners ASInvests in tools, technologies, and services enabling drug development at…series-a$26MJun 2026press
Eir VenturesBacks transformative Nordic life science innovations, from company creation to clinical…Jul 2024their site
1 more investors on record for Moleculent.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
The funds that backed Moleculent are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.